JP2022145646A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022145646A5 JP2022145646A5 JP2022042639A JP2022042639A JP2022145646A5 JP 2022145646 A5 JP2022145646 A5 JP 2022145646A5 JP 2022042639 A JP2022042639 A JP 2022042639A JP 2022042639 A JP2022042639 A JP 2022042639A JP 2022145646 A5 JP2022145646 A5 JP 2022145646A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- growth hormone
- rhgh
- recombinant human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163504P | 2021-03-19 | 2021-03-19 | |
| US63/163,504 | 2021-03-19 | ||
| US202163272417P | 2021-10-27 | 2021-10-27 | |
| US63/272,417 | 2021-10-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022145646A JP2022145646A (ja) | 2022-10-04 |
| JP2022145646A5 true JP2022145646A5 (https=) | 2025-03-24 |
Family
ID=83320806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022042639A Pending JP2022145646A (ja) | 2021-03-19 | 2022-03-17 | 長時間作用型成長ホルモンポリペプチドを投与する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240166710A1 (https=) |
| EP (1) | EP4308151A4 (https=) |
| JP (1) | JP2022145646A (https=) |
| KR (1) | KR20230171936A (https=) |
| AU (1) | AU2022238386A1 (https=) |
| BR (1) | BR112023018980A2 (https=) |
| CA (1) | CA3214273A1 (https=) |
| IL (1) | IL305661A (https=) |
| MX (1) | MX2023010997A (https=) |
| WO (1) | WO2022197961A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020155990A1 (en) * | 2001-04-20 | 2002-10-24 | Renasci, Inc., D/B/A Renasci Anti-Aging Center | Method of optimizing growth hormone replacement |
| WO2009102734A1 (en) * | 2008-02-11 | 2009-08-20 | Depomed Inc. | Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage form |
| US20150158926A1 (en) * | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
| RU2746943C2 (ru) * | 2013-10-21 | 2021-04-22 | Опко Байолоджикс Лтд. | Полипептиды длительного действия и способы их получения и введения |
| DK3220892T3 (da) * | 2014-11-21 | 2021-11-08 | Ascendis Pharma Endocrinology Div A/S | Langtidsvirkende væksthormondoseringsformer |
| HRP20230405T8 (hr) * | 2014-12-10 | 2023-09-29 | Opko Biologics Ltd. | Metode proizvodnje dugo djelujućih ctp-modificiranih polipeptida hormona rasta |
| JP7000153B2 (ja) * | 2014-12-10 | 2022-01-19 | オプコ バイオロジクス リミテッド | 長時間作用性ｃｔｐ修飾成長ホルモンポリペプチドを生成する方法 |
-
2022
- 2022-03-17 MX MX2023010997A patent/MX2023010997A/es unknown
- 2022-03-17 BR BR112023018980A patent/BR112023018980A2/pt unknown
- 2022-03-17 CA CA3214273A patent/CA3214273A1/en active Pending
- 2022-03-17 AU AU2022238386A patent/AU2022238386A1/en active Pending
- 2022-03-17 KR KR1020237035239A patent/KR20230171936A/ko active Pending
- 2022-03-17 EP EP22772229.5A patent/EP4308151A4/en active Pending
- 2022-03-17 JP JP2022042639A patent/JP2022145646A/ja active Pending
- 2022-03-17 IL IL305661A patent/IL305661A/en unknown
- 2022-03-17 US US18/282,844 patent/US20240166710A1/en active Pending
- 2022-03-17 WO PCT/US2022/020804 patent/WO2022197961A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Raymond et al. | Follow-up of children born of bromocriptine-treated mothers | |
| JP5731981B2 (ja) | インスリン及びｇｌｐ−１アゴニストの組み合わせ | |
| CN1178696C (zh) | 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂 | |
| CN101084009B (zh) | Gh促分泌素及其用途 | |
| US20250296973A1 (en) | Treatment method using mazdutide | |
| JP2003501397A (ja) | 糖尿病の治療方法 | |
| US4652547A (en) | Pharmaceutical formulations comprising human insulin and human proinsulin | |
| Ritzen et al. | Endocrine physiology and therapy in Prader-Willi syndrome | |
| JP2022145646A5 (https=) | ||
| WO2021143879A1 (en) | Combinational therapy comprising glp-1 and/or glp-1 analogs, and insulin and/or insulin analogs | |
| JP2008516994A (ja) | 成長ホルモン分泌促進因子およびその使用 | |
| CN121152634A (zh) | 用于治疗恶心和呕吐的方法和用途 | |
| WO2024168325A4 (en) | Administration of fibronectin based scaffold domain proteins totreat overweight, obesity, and related health conditions | |
| AU643073B2 (en) | Treatment of human lactation failure | |
| TAKANO et al. | Current clinical trials with authentic recombinant human growth hormone in Japan | |
| JPH0995455A (ja) | 腎機能改善剤 | |
| US6696414B2 (en) | Use of growth hormone in low dose | |
| US20260069586A1 (en) | Methods for reducing weight and preserving or increasing tissue lean mass in patients suffering from cushing's syndrome | |
| AU2006200127B2 (en) | Use of growth hormone in low dose | |
| EP0731710B1 (en) | Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease | |
| Ribeiro | Somatrogon. Long-acting human growth hormone, Treatment of human growth hormone deficiency | |
| Flyvbjerg et al. | 41 EVIDENCE THAT POTASSIUM DEFICIENCY INDUCES GROWTH RETARDATION THROUGH REDUCED SOMATOMEDIN C PRODUCTION | |
| WO1995012405A1 (en) | Method and composition for treatment of patients having decompensated liver disease | |
| Daily | ADVANCE ARTICLE | |
| HK1021685B (en) | Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease |